SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 132 filers reported holding SERES THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,875,492 | -77.8% | 788,022 | -55.2% | 0.00% | -75.0% |
| Q2 2023 | $8,429,988 | +363889.1% | 1,759,914 | +330.8% | 0.00% | +300.0% |
| Q1 2023 | $2,316 | +101.2% | 408,480 | +98.8% | 0.00% | 0.0% |
| Q4 2022 | $1,151 | -100.0% | 205,472 | -81.2% | 0.00% | -50.0% |
| Q2 2022 | $3,752,000 | -10.6% | 1,093,910 | +85.6% | 0.00% | 0.0% |
| Q1 2022 | $4,196,000 | -60.2% | 589,286 | -53.4% | 0.00% | -60.0% |
| Q4 2021 | $10,533,000 | +425.3% | 1,264,486 | +338.9% | 0.01% | +400.0% |
| Q3 2021 | $2,005,000 | -78.3% | 288,118 | -25.7% | 0.00% | -83.3% |
| Q2 2021 | $9,243,000 | +68.1% | 387,547 | +45.1% | 0.01% | +50.0% |
| Q1 2021 | $5,500,000 | -29.1% | 267,121 | -15.7% | 0.00% | -33.3% |
| Q4 2020 | $7,760,000 | -2.8% | 316,749 | +12.4% | 0.01% | -40.0% |
| Q3 2020 | $7,980,000 | +352.9% | 281,875 | -23.9% | 0.01% | +400.0% |
| Q2 2020 | $1,762,000 | +70.1% | 370,256 | +15.0% | 0.00% | 0.0% |
| Q2 2019 | $1,036,000 | -48.2% | 321,856 | +10.5% | 0.00% | -33.3% |
| Q1 2019 | $2,001,000 | +1686.6% | 291,290 | +1874.4% | 0.00% | – |
| Q3 2018 | $112,000 | -92.4% | 14,753 | -91.4% | 0.00% | -100.0% |
| Q2 2018 | $1,481,000 | +135.1% | 172,173 | +100.6% | 0.00% | +100.0% |
| Q1 2018 | $630,000 | -79.0% | 85,825 | -71.0% | 0.00% | -75.0% |
| Q4 2017 | $2,998,000 | -11.3% | 295,675 | +40.3% | 0.00% | -20.0% |
| Q3 2017 | $3,380,000 | +39.6% | 210,739 | -1.7% | 0.01% | 0.0% |
| Q2 2017 | $2,422,000 | -2.6% | 214,359 | -2.9% | 0.01% | 0.0% |
| Q1 2017 | $2,487,000 | +11.7% | 220,662 | -1.9% | 0.01% | 0.0% |
| Q4 2016 | $2,227,000 | +780.2% | 224,927 | +2261.4% | 0.01% | +400.0% |
| Q1 2016 | $253,000 | -95.9% | 9,525 | -94.6% | 0.00% | -92.3% |
| Q4 2015 | $6,158,000 | +101.2% | 175,503 | +70.0% | 0.01% | +116.7% |
| Q3 2015 | $3,060,000 | -11.1% | 103,253 | +24.5% | 0.01% | -14.3% |
| Q2 2015 | $3,442,000 | – | 82,931 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
| Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
| Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
| Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
| Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
| Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
| Knott David M Jr | 70,000 | $167 | 0.06% |
| XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
| FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |